Nautilus Biotechnology, Inc.

NASDAQ:NAUT

2.61 (USD) • At close November 1, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

202320222021202020192018
Revenue 000000
Cost of Revenue 5.7053.4162.8422.34600
Gross Profit -5.705-3.416-2.842-2.34600
Gross Profit Ratio 000000
Reseach & Development Expenses 47.25137.67229.35212.4320.0080
General & Administrative Expenses 28.90125.94621.1463.3120.002111.684
Selling & Marketing Expenses -3.85600000
SG&A 28.90125.94621.1463.3120.002111.684
Other Expenses 0-0.1220.1830.12500
Operating Expenses 76.15263.61850.49815.7440.01111.684
Operating Income -76.152-63.618-50.498-15.744-0.01-111.684
Operating Income Ratio 000000
Total Other Income Expenses Net 12.4775.6940.1830.1250738.284
Income Before Tax -63.675-57.924-50.315-15.619-0.01626.6
Income Before Tax Ratio 000000
Income Tax Expense 05.8162.6052.14-0.171738.123
Net Income -63.675-63.74-50.315-15.619-0.01626.6
Net Income Ratio 000000
EPS -0.51-0.51-0.6-0.52-0.00187.18
EPS Diluted -0.51-0.51-0.6-0.52-0.00187.18
EBITDA -74.303-60.202-47.656-13.398-0.01626.6
EBITDA Ratio 000000